25 research outputs found
Genetic and Epigenetic Mechanisms Underlying Stress-Induced Behavioral Change
Social stress is the most common stressor experienced by humans and exposure to social stress is thought to cause or exacerbate neuropsychiatric illness. Social stress also leads to behavioral and physiological responses in many animal models that closely mirror the symptoms of fear and anxiety in humans. Our laboratory uses Syrian hamsters to study behavioral responses to social stress. Hamsters are highly territorial, but after losing an agonistic encounter, hamsters exhibit a striking behavioral change, abandoning all territorial aggression and instead becoming highly submissive. This behavioral shift is termed conditioned defeat. Epigenetic modifications, such as changes in histone acetylation, are a possible molecular mechanism underlying such behavioral shifts. Histone deacetylase (HDAC) inhibitors have been shown to enhance fear learning and conditioned place preference for drugs of abuse, while suppressing histone acetylation with histone acetyltransferase (HAT) inhibitors impairs long-term memory formation. The first goal of this study was to test the hypothesis that histone acetylation is a molecular mechanism underlying conditioned defeat. We found that animals given an HDAC inhibitor systemically before social defeat later exhibited increased conditioned defeat. This treatment also suppressed defeat-induced immediate-early gene activity in the infralimbic cortex but not the basolateral amygdala. Next, we demonstrated that administration of an HDAC inhibitor in the infralimbic cortex before defeat enhanced stress-induced behavioral responses while HAT inhibition blocked these behavioral changes. Although both males and females exhibit conditioned defeat, the behavioral expression is more pronounced in males. We next used transcriptomic analysis to investigate potential genetic mechanisms leading to this sexually dimorphic expression and to further delineate the role of acetylation in stress-induced behavioral changes. We sequenced the whole brain transcriptome of male and female hamsters as well as the transcriptome of basolateral amygdala, a nucleus necessary for the acquisition and expression of conditioned defeat, of dominant, subordinate, and control animals. Our analysis revealed that numerous genes relating to histone acetylation, including several HDACs, were differentially expressed in animals of different social status and between sexes. Together, these data support the hypotheses that histone modifications underlie behavioral responses to social stress and that some of these modifications are sexually dimorphic
The neurotoxin DSP-4 dysregulates the locus coeruleus-norepinephrine system and recapitulates molecular and behavioral aspects of prodromal neurodegenerative disease
The noradrenergic locus coeruleus (LC) is among the earliest sites of tau and α-synuclein pathology in Alzheimer\u27s disease (AD) and Parkinson\u27s disease (PD), respectively. The onset of these pathologies coincides with loss of noradrenergic fibers in LC target regions and the emergence of prodromal symptoms including sleep disturbances and anxiety. Paradoxically, these prodromal symptoms are indicative of a noradrenergic hyperactivity phenotype, rather than the predicted loss of norepinephrine (NE) transmission following LC damage, suggesting the engagement of complex compensatory mechanisms. Because current therapeutic efforts are targeting early disease, interest in the LC has grown, and it is critical to identify the links between pathology and dysfunction. We employed the LC-specific neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4), which preferentially damages LC axons, to model early changes in the LC-NE system pertinent to AD and PD in male and female mice. DSP-4 (two doses of 50 mg/kg, one week apart) induced LC axon degeneration, triggered neuroinflammation and oxidative stress, and reduced tissue NE levels. There was no LC cell death or changes to LC firing, but transcriptomics revealed reduced expression of genes that define noradrenergic identity and other changes relevant to neurodegenerative disease. Despite the dramatic loss of LC fibers, NE turnover and signaling were elevated in terminal regions and were associated with anxiogenic phenotypes in multiple behavioral tests. These results represent a comprehensive analysis of how the LC-NE system responds to axon/terminal damage reminiscent of early AD and PD at the molecular, cellular, systems, and behavioral levels, and provides potential mechanisms underlying prodromal neuropsychiatric symptoms
Measuring Behavior in the Home Cage : Study Design, Applications, Challenges, and Perspectives
FUNDING This research was supported by NIH grants R00AG056662, P20GM125528, AG057424 to WS and SLPeer reviewedPublisher PD
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
Multiple sclerosis is a common disease of the central nervous system in which the interplay between inflammatory and neurodegenerative processes typically results in intermittent neurological disturbance followed by progressive accumulation of disability. Epidemiological studies have shown that genetic factors are primarily responsible for the substantially increased frequency of the disease seen in the relatives of affected individuals, and systematic attempts to identify linkage in multiplex families have confirmed that variation within the major histocompatibility complex (MHC) exerts the greatest individual effect on risk. Modestly powered genome-wide association studies (GWAS) have enabled more than 20 additional risk loci to be identified and have shown that multiple variants exerting modest individual effects have a key role in disease susceptibility. Most of the genetic architecture underlying susceptibility to the disease remains to be defined and is anticipated to require the analysis of sample sizes that are beyond the numbers currently available to individual research groups. In a collaborative GWAS involving 9,772 cases of European descent collected by 23 research groups working in 15 different countries, we have replicated almost all of the previously suggested associations and identified at least a further 29 novel susceptibility loci. Within the MHC we have refined the identity of the HLA-DRB1 risk alleles and confirmed that variation in the HLA-A gene underlies the independent protective effect attributable to the class I region. Immunologically relevant genes are significantly overrepresented among those mapping close to the identified loci and particularly implicate T-helper-cell differentiation in the pathogenesis of multiple sclerosis
Corrigendum to “Acute and repeated exposure to social stress reduces gut microbiota diversity in Syrian hamsters” [Behav. Brain Res. 345 (2018) 39–48]
Effects of inescapable versus escapable social stress in Syrian hamsters: The importance of stressor duration versus escapability
The effect of escapable versus inescapable social defeat on conditioned defeat and social recognition in Syrian hamsters
Oxytocin induces social communication by activating arginine-vasopressin V1a receptors and not oxytocin receptors
Histone deacetylase and acetyltransferase inhibitors modulate behavioral responses to social stress
Genetic and immunopathological analysis of CHCHD10 in Australian amyotrophic lateral sclerosis and frontotemporal dementia and transgenic TDP-43 mice
Objective: Since the first report of CHCHD10 gene mutations in amyotrophiclateral sclerosis (ALS)/frontotemporaldementia (FTD) patients, genetic variation in CHCHD10 has been inconsistently linked to disease. A pathological assessment of the CHCHD10 protein in patient neuronal tissue also remains to be reported. We sought to characterise the genetic and pathological contribution of CHCHD10 to ALS/FTD in Australia. Methods: Whole-exome and whole-genome sequencing data from 81 familial and 635 sporadic ALS, and 108 sporadic FTD cases, were assessed for genetic variation in CHCHD10. CHCHD10 protein expression was characterised by immunohistochemistry, immunofluorescence and western blotting in control, ALS and/or FTD postmortem tissues and further in a transgenic mouse model of TAR DNA-binding protein 43 (TDP-43) pathology. Results: No causal, novel or disease-associated variants in CHCHD10 were identified in Australian ALS and/or FTD patients. In human brain and spinal cord tissues, CHCHD10 was specifically expressed in neurons. A significant decrease in CHCHD10 protein level was observed in ALS patient spinal cord and FTD patient frontal cortex. In a TDP-43 mouse model with a regulatable nuclear localisation signal (rNLS TDP-43 mouse), CHCHD10 protein levels were unaltered at disease onset and early in disease, but were significantly decreased in cortex in mid-stage disease. Conclusions: Genetic variation in CHCHD10 is not a common cause of ALS/FTD in Australia. However, we showed that in humans, CHCHD10 may play a neuron-specific role and a loss of CHCHD10 function may be linked to ALS and/or FTD. Our data from the rNLS TDP-43 transgenic mice suggest that a decrease in CHCHD10 levels is a late event in aberrant TDP-43-induced ALS/FTD pathogenesis